Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP82139.RAQ_qtb1-6wzCOFyQfIHS2KoyN7oxTbnzYqJ4zvfhQrLk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP82139.RAQ_qtb1-6wzCOFyQfIHS2KoyN7oxTbnzYqJ4zvfhQrLk130_assertion type Assertion NP82139.RAQ_qtb1-6wzCOFyQfIHS2KoyN7oxTbnzYqJ4zvfhQrLk130_head.
- NP82139.RAQ_qtb1-6wzCOFyQfIHS2KoyN7oxTbnzYqJ4zvfhQrLk130_assertion description "[In conclusion, in early-stage patients with CLL, we found no correlation between expression and the mutations or polymorphism in BCL6, but high levels of BCL6 can discriminate patients with a worse prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82139.RAQ_qtb1-6wzCOFyQfIHS2KoyN7oxTbnzYqJ4zvfhQrLk130_provenance.
- NP82139.RAQ_qtb1-6wzCOFyQfIHS2KoyN7oxTbnzYqJ4zvfhQrLk130_assertion evidence source_evidence_literature NP82139.RAQ_qtb1-6wzCOFyQfIHS2KoyN7oxTbnzYqJ4zvfhQrLk130_provenance.
- NP82139.RAQ_qtb1-6wzCOFyQfIHS2KoyN7oxTbnzYqJ4zvfhQrLk130_assertion SIO_000772 19367498 NP82139.RAQ_qtb1-6wzCOFyQfIHS2KoyN7oxTbnzYqJ4zvfhQrLk130_provenance.
- NP82139.RAQ_qtb1-6wzCOFyQfIHS2KoyN7oxTbnzYqJ4zvfhQrLk130_assertion wasDerivedFrom gad-20130706 NP82139.RAQ_qtb1-6wzCOFyQfIHS2KoyN7oxTbnzYqJ4zvfhQrLk130_provenance.
- NP82139.RAQ_qtb1-6wzCOFyQfIHS2KoyN7oxTbnzYqJ4zvfhQrLk130_assertion wasGeneratedBy ECO_0000203 NP82139.RAQ_qtb1-6wzCOFyQfIHS2KoyN7oxTbnzYqJ4zvfhQrLk130_provenance.